Diagnostic devices that are used at home or in doctors' offices are often not sensitive enough to detect small amounts of a virus that might be present in samples from asymptomatic patients, which can occur in early stage COVID-19. In Biomicrofluidics,, scientists report a membrane-based invention that can concentrate the virus content of a sample of urine or saliva, allowing it to be detected.